Experts: Trump’s FDA moves create uncertainty, opportunities for other regulators
Regulatory NewsFerdous Al-Faruque
Biologics/ biosimilars/ vaccinesGovernment/legislationGuidanceMedical DevicesPharmaceuticalsRegulatory harmonizationRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)